ADS adds Libre 2 Plus sensor
By HME News Staff
Updated 10:39 AM CST, Wed January 31, 2024
CARLSBAD, Calif. — Advanced Diabetes Supply (ADS), a national distributor of diabetes devices under the ADS and US MED brands, is now carrying the new FreeStyle Libre 2 Plus sensor, the first DME provider in the country to offer consumers the 15-day sensor. “The FreeStyle Libre 2 Plus is an exciting advancement in diabetes health technology and is the only 15-day non-implantable continuous glucose monitoring (CGM) sensor in the U.S.,” said Bill Mixon, CEO of ADS. “As leading distributors of FreeStyle Libre, we are pleased to be the first to add this valuable tool to our product offerings as we continue to seek new and innovative ways to support the diabetic community.” The FreeStyle Libre 2 Plus sensor, developed by Abbott, currently integrates with the Tandem t:slim X2 insulin pump with Control-IQ technology, the No. 1 rated automated insulin delivery system. It is approved for use in patients as young as 2 years old and offers users improved accuracy, particularly in the low glucose range. The FreeStyle Libre 2 Plus is expected to integrate with other automated insulin delivery devices, such as the Omnipod Dash, in the future. ADS and US MED were part of the beta testing for the new sensor, reflecting the longstanding commitment by the industries to support technologies that advance care and support the needs of the diabetic community.
Comments